Home / Import refusals / AEK-3225077-9/11/1

FDA Import Refusal AEK-3225077-9/11/1 — MYLAN PHARMACEUTICALS

MYLAN PHARMACEUTICALS — FEI 3026962410

The FDA refused shipment AEK-3225077-9/11/1 from MYLAN PHARMACEUTICALS (India) on May 8, 2023. The refused product falls under Drugs and Biologics — EFAVIRENZ (ANTI-VIRAL). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 8, 2023
Country
India
Product Category
Drugs and Biologics
Product Code
62VCA24 EFAVIRENZ (ANTI-VIRAL)
Charges
118,75

Other import refusals

  • AEK-4732872-7/11/1 (Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2783875-2/11/1 (Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2786470-9/11/1 (Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-1068884-6/21/1 (Fri Aug 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8237854-4/21/1 (Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources